SCHEMBL7522945

SCHEMBL7522945

CC(C)NC(=O)c1ccccc1.[LiH]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.56
ALDH1A1 P00352 5/20 0.56
HPGD P15428 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
RAB9A P51151 1/20 0.56
NPSR1 Q6W5P4 2/20 0.54
TDP1 Q9NUW8 2/20 0.53
KDM4E B2RXH2 1/20 0.53
LMNA P02545 4/20 0.53
GAA P10253 2/20 0.53
ALOX12 P18054 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
ALOX15 P16050 2/20 0.52
HDAC1 Q13547 2/20 0.52
HDAC3 O15379 1/20 0.52
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
IDO1 P14902 1/20 0.52
CA9 Q16790 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29772431 0.98 MLYCD (0.58) MLYCDALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL24998749 0.98 MLYCD (0.58) MLYCDALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL155518 0.98 MLYCD (0.58) MLYCDALDH1A1HPGDSMN1; SMN2RAB9A
Hydrochloric Acid SCHEMBL7849680 0.96 MLYCD (0.56) MLYCDALDH1A1HPGDSMN1; SMN2RAB9A
Hydrochloric Acid SCHEMBL28544859 0.96 MLYCD (0.56) MLYCDALDH1A1HPGDSMN1; SMN2RAB9A
Oxalic Acid SCHEMBL30439587 0.94 MLYCD (0.55) MLYCDALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL4046626 0.92 MLYCD (0.53) MLYCDALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL13753392 0.90 ALDH1A1 (0.70) MLYCDALDH1A1HPGDSMN1; SMN2RAB9A
Formic Acid SCHEMBL15389361 0.90 HPGD (0.56) MLYCDALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL3209451 0.90 ALDH1A1 (0.51) MLYCDALDH1A1HPGDSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020107391-A1 Process for the synthesis of an endothelin receptor antagonist FREY LISA F (US) 2002-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107391-A1 Process for the synthesis of an endothelin receptor antagonist EDNRA, EDNRB, AGTR2 MLYCD 1979/4885ALDH1A1 3702/4885HPGD 837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.